Structure

Physi-Chem Properties

Molecular Weight:  298.18
Volume:  295.018
LogP:  3.611
LogD:  3.406
LogS:  -4.897
# Rotatable Bonds:  1
TPSA:  46.15
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.697
Synthetic Accessibility Score:  5.734
Fsp3:  1.0
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.616
MDCK Permeability:  5.521794082596898e-05
Pgp-inhibitor:  0.76
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.03

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.226
Plasma Protein Binding (PPB):  76.00823211669922%
Volume Distribution (VD):  1.907
Pgp-substrate:  13.220451354980469%

ADMET: Metabolism

CYP1A2-inhibitor:  0.049
CYP1A2-substrate:  0.988
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.932
CYP2C9-inhibitor:  0.029
CYP2C9-substrate:  0.034
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.799
CYP3A4-inhibitor:  0.118
CYP3A4-substrate:  0.515

ADMET: Excretion

Clearance (CL):  12.471
Half-life (T1/2):  0.305

ADMET: Toxicity

hERG Blockers:  0.809
Human Hepatotoxicity (H-HT):  0.964
Drug-inuced Liver Injury (DILI):  0.838
AMES Toxicity:  0.587
Rat Oral Acute Toxicity:  0.264
Maximum Recommended Daily Dose:  0.029
Skin Sensitization:  0.612
Carcinogencity:  0.607
Eye Corrosion:  0.196
Eye Irritation:  0.475
Respiratory Toxicity:  0.978

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC52087

Natural Product ID:  NPC52087
Common Name*:   Hispolon
IUPAC Name:   (3Z,5E)-6-(3,4-dihydroxyphenyl)-4-hydroxyhexa-3,5-dien-2-one
Synonyms:   Hispolon
Standard InCHIKey:  QDVIEIMMEUCFMW-QXYPORFMSA-N
Standard InCHI:  InChI=1S/C12H12O4/c1-8(13)6-10(14)4-2-9-3-5-11(15)12(16)7-9/h2-7,14-16H,1H3/b4-2+,10-6-
SMILES:  CC(=O)/C=C(/C=C/c1ccc(c(c1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL452722
PubChem CID:   10082188
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0001286] Benzenediols
          • [CHEMONTID:0000135] Catechols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[15165144]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[15844878]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[16209522]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[17279797]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[20583752]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO13213 Inonotus hispidus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO13213 Inonotus hispidus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO24588 Phellinus igniarius Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13213 Inonotus hispidus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 = 183.0 nM PMID[550597]
NPT547 Cell Line BGC-823 Homo sapiens IC50 = 205.0 nM PMID[550597]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 25.0 nM PMID[550597]
NPT181 Cell Line Bel-7402 Homo sapiens IC50 = 38.0 nM PMID[550597]
NPT1085 Cell Line KETR3 Homo sapiens IC50 = 206.0 nM PMID[550597]
NPT180 Cell Line HCT-8 Homo sapiens IC50 = 199.0 nM PMID[550597]
NPT2657 Cell Line A10 Rattus norvegicus IC50 = 37.05 ug.mL-1 PMID[550598]
NPT2657 Cell Line A10 Rattus norvegicus Activity < 10.0 % PMID[550598]
NPT3151 Individual Protein Focal adhesion kinase 1 Rattus norvegicus Inhibition = 12.0 % PMID[550598]
NPT3151 Individual Protein Focal adhesion kinase 1 Rattus norvegicus Inhibition = 6.51 % PMID[550598]
NPT3151 Individual Protein Focal adhesion kinase 1 Rattus norvegicus Inhibition = 43.21 % PMID[550598]
NPT90 Cell Line DU-145 Homo sapiens IC50 = 28600.0 nM PMID[550599]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 7900.0 nM PMID[550599]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 32200.0 nM PMID[550599]
NPT616 Cell Line MDCK Canis lupus familiaris IC50 = 36200.0 nM PMID[550599]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 7300.0 nM PMID[550599]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 9600.0 nM PMID[550599]
NPT71 Cell Line HEK293 Homo sapiens Ratio IC50 = 1.3 n.a. PMID[550599]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 25.0 % PMID[550598]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 58.0 % PMID[550598]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 12900.0 nM PMID[550599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 5200.0 nM PMID[550599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 8400.0 nM PMID[550599]
NPT27 Others Unspecified IC50 = 51200.0 nM PMID[550599]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC52087 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9794 High Similarity NPC79672
0.94 High Similarity NPC1075
0.94 High Similarity NPC1786
0.94 High Similarity NPC294902
0.9271 High Similarity NPC107522
0.9208 High Similarity NPC19149
0.9135 High Similarity NPC297657
0.9135 High Similarity NPC226250
0.9091 High Similarity NPC223393
0.9082 High Similarity NPC109955
0.9048 High Similarity NPC51698
0.899 High Similarity NPC131587
0.8962 High Similarity NPC95381
0.8911 High Similarity NPC196479
0.8879 High Similarity NPC33749
0.8879 High Similarity NPC261453
0.8879 High Similarity NPC328593
0.8868 High Similarity NPC131530
0.8866 High Similarity NPC181709
0.8824 High Similarity NPC120719
0.8824 High Similarity NPC471511
0.8812 High Similarity NPC110764
0.8796 High Similarity NPC233669
0.8796 High Similarity NPC474967
0.8725 High Similarity NPC477801
0.8725 High Similarity NPC477802
0.8716 High Similarity NPC281277
0.8716 High Similarity NPC61062
0.8716 High Similarity NPC277394
0.8716 High Similarity NPC299252
0.8704 High Similarity NPC217472
0.8679 High Similarity NPC222084
0.8654 High Similarity NPC477814
0.8641 High Similarity NPC12278
0.8636 High Similarity NPC65791
0.8636 High Similarity NPC150919
0.8611 High Similarity NPC264558
0.8611 High Similarity NPC148969
0.8585 High Similarity NPC228343
0.8585 High Similarity NPC254833
0.8559 High Similarity NPC164706
0.8559 High Similarity NPC203124
0.8559 High Similarity NPC70744
0.8559 High Similarity NPC272471
0.8559 High Similarity NPC107588
0.8559 High Similarity NPC137537
0.8559 High Similarity NPC309434
0.8558 High Similarity NPC239291
0.85 High Similarity NPC257182
0.8496 Intermediate Similarity NPC109083
0.8496 Intermediate Similarity NPC189844
0.8496 Intermediate Similarity NPC269843
0.8496 Intermediate Similarity NPC60962
0.8496 Intermediate Similarity NPC224814
0.8496 Intermediate Similarity NPC158949
0.8496 Intermediate Similarity NPC14007
0.8491 Intermediate Similarity NPC34864
0.8491 Intermediate Similarity NPC105727
0.8491 Intermediate Similarity NPC58427
0.8491 Intermediate Similarity NPC114392
0.8482 Intermediate Similarity NPC241634
0.8482 Intermediate Similarity NPC117759
0.8468 Intermediate Similarity NPC278652
0.8468 Intermediate Similarity NPC39793
0.8431 Intermediate Similarity NPC130193
0.8411 Intermediate Similarity NPC7097
0.8411 Intermediate Similarity NPC246358
0.8411 Intermediate Similarity NPC36108
0.8411 Intermediate Similarity NPC233731
0.8407 Intermediate Similarity NPC2058
0.8407 Intermediate Similarity NPC202474
0.84 Intermediate Similarity NPC32977
0.84 Intermediate Similarity NPC81010
0.8396 Intermediate Similarity NPC176527
0.8393 Intermediate Similarity NPC275519
0.8348 Intermediate Similarity NPC286573
0.8333 Intermediate Similarity NPC147634
0.8333 Intermediate Similarity NPC79793
0.8333 Intermediate Similarity NPC201967
0.8333 Intermediate Similarity NPC248817
0.8333 Intermediate Similarity NPC470849
0.8333 Intermediate Similarity NPC120982
0.8333 Intermediate Similarity NPC470848
0.8333 Intermediate Similarity NPC204466
0.8333 Intermediate Similarity NPC174096
0.8333 Intermediate Similarity NPC236520
0.8333 Intermediate Similarity NPC294361
0.8333 Intermediate Similarity NPC226401
0.8333 Intermediate Similarity NPC150837
0.8319 Intermediate Similarity NPC263386
0.8319 Intermediate Similarity NPC141791
0.8318 Intermediate Similarity NPC233835
0.8317 Intermediate Similarity NPC286006
0.8304 Intermediate Similarity NPC200988
0.8304 Intermediate Similarity NPC145023
0.8304 Intermediate Similarity NPC175799
0.8304 Intermediate Similarity NPC610
0.8288 Intermediate Similarity NPC4665
0.8276 Intermediate Similarity NPC229084
0.8276 Intermediate Similarity NPC160900
0.8276 Intermediate Similarity NPC18984
0.8276 Intermediate Similarity NPC306100
0.8276 Intermediate Similarity NPC106659
0.8276 Intermediate Similarity NPC238810
0.8269 Intermediate Similarity NPC94343
0.8265 Intermediate Similarity NPC27974
0.8261 Intermediate Similarity NPC70752
0.8257 Intermediate Similarity NPC257124
0.8257 Intermediate Similarity NPC470355
0.8257 Intermediate Similarity NPC139617
0.8257 Intermediate Similarity NPC78918
0.8257 Intermediate Similarity NPC173746
0.8257 Intermediate Similarity NPC187583
0.8257 Intermediate Similarity NPC8547
0.8257 Intermediate Similarity NPC179002
0.8257 Intermediate Similarity NPC156840
0.8257 Intermediate Similarity NPC257430
0.8257 Intermediate Similarity NPC268032
0.8247 Intermediate Similarity NPC197783
0.8241 Intermediate Similarity NPC62258
0.8241 Intermediate Similarity NPC55617
0.823 Intermediate Similarity NPC86198
0.8229 Intermediate Similarity NPC265146
0.8229 Intermediate Similarity NPC124436
0.8198 Intermediate Similarity NPC294941
0.819 Intermediate Similarity NPC68269
0.819 Intermediate Similarity NPC114298
0.819 Intermediate Similarity NPC86900
0.8174 Intermediate Similarity NPC98305
0.8173 Intermediate Similarity NPC253746
0.8163 Intermediate Similarity NPC184169
0.8163 Intermediate Similarity NPC23167
0.8158 Intermediate Similarity NPC299406
0.8158 Intermediate Similarity NPC109371
0.8158 Intermediate Similarity NPC470215
0.8158 Intermediate Similarity NPC70084
0.8158 Intermediate Similarity NPC470214
0.8155 Intermediate Similarity NPC260000
0.8144 Intermediate Similarity NPC175313
0.8142 Intermediate Similarity NPC280001
0.8137 Intermediate Similarity NPC274678
0.8136 Intermediate Similarity NPC197832
0.8125 Intermediate Similarity NPC278102
0.812 Intermediate Similarity NPC242372
0.812 Intermediate Similarity NPC257976
0.812 Intermediate Similarity NPC4181
0.812 Intermediate Similarity NPC164778
0.8113 Intermediate Similarity NPC93831
0.8108 Intermediate Similarity NPC471485
0.8103 Intermediate Similarity NPC147654
0.8095 Intermediate Similarity NPC472585
0.8091 Intermediate Similarity NPC280382
0.8087 Intermediate Similarity NPC265454
0.8087 Intermediate Similarity NPC34634
0.8081 Intermediate Similarity NPC25493
0.8081 Intermediate Similarity NPC104216
0.8081 Intermediate Similarity NPC113460
0.8081 Intermediate Similarity NPC19680
0.8077 Intermediate Similarity NPC280869
0.807 Intermediate Similarity NPC212743
0.807 Intermediate Similarity NPC63126
0.8067 Intermediate Similarity NPC84076
0.8067 Intermediate Similarity NPC276014
0.8067 Intermediate Similarity NPC90128
0.8067 Intermediate Similarity NPC303680
0.8056 Intermediate Similarity NPC34715
0.8051 Intermediate Similarity NPC20443
0.8051 Intermediate Similarity NPC273686
0.8051 Intermediate Similarity NPC146886
0.8051 Intermediate Similarity NPC246704
0.8051 Intermediate Similarity NPC312404
0.8051 Intermediate Similarity NPC60517
0.8037 Intermediate Similarity NPC127676
0.8036 Intermediate Similarity NPC142599
0.8036 Intermediate Similarity NPC120280
0.802 Intermediate Similarity NPC270547
0.802 Intermediate Similarity NPC231150
0.802 Intermediate Similarity NPC304541
0.802 Intermediate Similarity NPC155908
0.8019 Intermediate Similarity NPC304638
0.8019 Intermediate Similarity NPC135784
0.8018 Intermediate Similarity NPC231717
0.8018 Intermediate Similarity NPC146422
0.8 Intermediate Similarity NPC242240
0.8 Intermediate Similarity NPC123228
0.8 Intermediate Similarity NPC177420
0.8 Intermediate Similarity NPC5018
0.8 Intermediate Similarity NPC123722
0.8 Intermediate Similarity NPC280347
0.8 Intermediate Similarity NPC156654
0.8 Intermediate Similarity NPC276466
0.8 Intermediate Similarity NPC123273
0.8 Intermediate Similarity NPC258219
0.8 Intermediate Similarity NPC318325
0.8 Intermediate Similarity NPC151167
0.8 Intermediate Similarity NPC98772
0.7983 Intermediate Similarity NPC300326
0.7983 Intermediate Similarity NPC142776
0.7983 Intermediate Similarity NPC289459
0.7983 Intermediate Similarity NPC58279

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC52087 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8585 High Similarity NPD3021 Approved
0.8585 High Similarity NPD3022 Approved
0.8276 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.8257 Intermediate Similarity NPD228 Approved
0.8229 Intermediate Similarity NPD111 Approved
0.8018 Intermediate Similarity NPD9379 Approved
0.8018 Intermediate Similarity NPD9377 Approved
0.8 Intermediate Similarity NPD9280 Clinical (unspecified phase)
0.7864 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7864 Intermediate Similarity NPD2934 Approved
0.7864 Intermediate Similarity NPD2933 Approved
0.783 Intermediate Similarity NPD1242 Phase 1
0.7788 Intermediate Similarity NPD2859 Approved
0.7788 Intermediate Similarity NPD844 Approved
0.7788 Intermediate Similarity NPD2860 Approved
0.7736 Intermediate Similarity NPD3020 Approved
0.7714 Intermediate Similarity NPD288 Approved
0.7705 Intermediate Similarity NPD9494 Approved
0.7672 Intermediate Similarity NPD5536 Phase 2
0.7664 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7623 Intermediate Similarity NPD258 Approved
0.7623 Intermediate Similarity NPD257 Approved
0.7583 Intermediate Similarity NPD9269 Phase 2
0.754 Intermediate Similarity NPD943 Approved
0.7479 Intermediate Similarity NPD9384 Approved
0.7479 Intermediate Similarity NPD9381 Approved
0.7459 Intermediate Similarity NPD9634 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD940 Approved
0.7431 Intermediate Similarity NPD846 Approved
0.7419 Intermediate Similarity NPD9569 Approved
0.7377 Intermediate Similarity NPD9622 Approved
0.7344 Intermediate Similarity NPD230 Phase 1
0.7323 Intermediate Similarity NPD259 Phase 1
0.7308 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7295 Intermediate Similarity NPD2337 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD1809 Phase 2
0.7282 Intermediate Similarity NPD9094 Approved
0.7266 Intermediate Similarity NPD826 Approved
0.7266 Intermediate Similarity NPD825 Approved
0.7264 Intermediate Similarity NPD845 Approved
0.7258 Intermediate Similarity NPD3055 Approved
0.7258 Intermediate Similarity NPD3053 Approved
0.7257 Intermediate Similarity NPD1358 Approved
0.7257 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD1357 Approved
0.725 Intermediate Similarity NPD9268 Approved
0.7209 Intermediate Similarity NPD275 Approved
0.7209 Intermediate Similarity NPD274 Approved
0.7209 Intermediate Similarity NPD555 Phase 2
0.7207 Intermediate Similarity NPD9500 Approved
0.72 Intermediate Similarity NPD9621 Approved
0.72 Intermediate Similarity NPD9619 Approved
0.72 Intermediate Similarity NPD9620 Approved
0.7197 Intermediate Similarity NPD7266 Discontinued
0.7196 Intermediate Similarity NPD9296 Approved
0.719 Intermediate Similarity NPD2932 Approved
0.719 Intermediate Similarity NPD3019 Approved
0.7179 Intermediate Similarity NPD5283 Phase 1
0.7177 Intermediate Similarity NPD5310 Approved
0.7177 Intermediate Similarity NPD5311 Approved
0.7168 Intermediate Similarity NPD1445 Approved
0.7168 Intermediate Similarity NPD1444 Approved
0.7165 Intermediate Similarity NPD9536 Phase 1
0.7165 Intermediate Similarity NPD3027 Phase 3
0.7165 Intermediate Similarity NPD9537 Phase 1
0.7164 Intermediate Similarity NPD8166 Discontinued
0.7143 Intermediate Similarity NPD9608 Approved
0.7143 Intermediate Similarity NPD9610 Approved
0.7143 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD9087 Approved
0.7049 Intermediate Similarity NPD4626 Approved
0.7027 Intermediate Similarity NPD3028 Approved
0.7025 Intermediate Similarity NPD9545 Approved
0.7018 Intermediate Similarity NPD3134 Approved
0.7008 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.6983 Remote Similarity NPD1792 Phase 2
0.6983 Remote Similarity NPD4750 Phase 3
0.6977 Remote Similarity NPD598 Approved
0.6977 Remote Similarity NPD601 Approved
0.6977 Remote Similarity NPD3145 Approved
0.6977 Remote Similarity NPD597 Approved
0.6977 Remote Similarity NPD3144 Approved
0.697 Remote Similarity NPD9088 Approved
0.6935 Remote Similarity NPD3092 Approved
0.6935 Remote Similarity NPD1201 Approved
0.6923 Remote Similarity NPD1136 Approved
0.6923 Remote Similarity NPD1132 Approved
0.6923 Remote Similarity NPD2674 Phase 3
0.6923 Remote Similarity NPD1130 Approved
0.6917 Remote Similarity NPD255 Approved
0.6917 Remote Similarity NPD256 Approved
0.6897 Remote Similarity NPD74 Approved
0.6897 Remote Similarity NPD9266 Approved
0.6897 Remote Similarity NPD2684 Approved
0.6891 Remote Similarity NPD2228 Approved
0.6891 Remote Similarity NPD2234 Approved
0.6891 Remote Similarity NPD2229 Approved
0.6885 Remote Similarity NPD3091 Approved
0.6884 Remote Similarity NPD1511 Approved
0.687 Remote Similarity NPD1612 Clinical (unspecified phase)
0.687 Remote Similarity NPD1558 Phase 1
0.687 Remote Similarity NPD1613 Approved
0.687 Remote Similarity NPD3059 Approved
0.687 Remote Similarity NPD3061 Approved
0.687 Remote Similarity NPD3062 Approved
0.6866 Remote Similarity NPD9570 Approved
0.6861 Remote Similarity NPD6190 Approved
0.686 Remote Similarity NPD9493 Approved
0.6855 Remote Similarity NPD3496 Discontinued
0.685 Remote Similarity NPD1470 Approved
0.685 Remote Similarity NPD3094 Phase 2
0.6847 Remote Similarity NPD9273 Approved
0.6846 Remote Similarity NPD2028 Clinical (unspecified phase)
0.6838 Remote Similarity NPD9380 Clinical (unspecified phase)
0.6833 Remote Similarity NPD9614 Approved
0.6833 Remote Similarity NPD9618 Approved
0.6829 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6818 Remote Similarity NPD447 Suspended
0.681 Remote Similarity NPD290 Approved
0.681 Remote Similarity NPD9264 Approved
0.681 Remote Similarity NPD9263 Approved
0.681 Remote Similarity NPD9267 Approved
0.681 Remote Similarity NPD2342 Discontinued
0.6807 Remote Similarity NPD7635 Approved
0.6807 Remote Similarity NPD7843 Approved
0.68 Remote Similarity NPD422 Phase 1
0.6786 Remote Similarity NPD1512 Approved
0.6777 Remote Similarity NPD6671 Approved
0.6777 Remote Similarity NPD7157 Approved
0.6774 Remote Similarity NPD4059 Approved
0.6767 Remote Similarity NPD5314 Approved
0.675 Remote Similarity NPD1241 Discontinued
0.6742 Remote Similarity NPD4060 Phase 1
0.6742 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6742 Remote Similarity NPD3620 Phase 2
0.6738 Remote Similarity NPD711 Discontinued
0.6724 Remote Similarity NPD968 Approved
0.6723 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6721 Remote Similarity NPD9568 Approved
0.672 Remote Similarity NPD3023 Approved
0.672 Remote Similarity NPD3026 Approved
0.67 Remote Similarity NPD9294 Approved
0.6699 Remote Similarity NPD9089 Approved
0.6694 Remote Similarity NPD475 Phase 2
0.6694 Remote Similarity NPD4093 Discontinued
0.6694 Remote Similarity NPD3025 Approved
0.6694 Remote Similarity NPD3024 Approved
0.6694 Remote Similarity NPD1793 Approved
0.6694 Remote Similarity NPD1791 Approved
0.6694 Remote Similarity NPD5691 Approved
0.6693 Remote Similarity NPD2982 Phase 2
0.6693 Remote Similarity NPD1755 Approved
0.6693 Remote Similarity NPD2983 Phase 2
0.6693 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6667 Remote Similarity NPD9616 Approved
0.6667 Remote Similarity NPD9615 Approved
0.6667 Remote Similarity NPD9613 Approved
0.6667 Remote Similarity NPD291 Approved
0.6643 Remote Similarity NPD3455 Phase 2
0.6642 Remote Similarity NPD817 Approved
0.6642 Remote Similarity NPD823 Approved
0.6641 Remote Similarity NPD7095 Approved
0.664 Remote Similarity NPD2286 Discontinued
0.664 Remote Similarity NPD1751 Approved
0.664 Remote Similarity NPD3095 Discontinued
0.6621 Remote Similarity NPD1934 Approved
0.6618 Remote Similarity NPD1632 Clinical (unspecified phase)
0.6615 Remote Similarity NPD5736 Approved
0.6614 Remote Similarity NPD2981 Phase 2
0.6613 Remote Similarity NPD316 Approved
0.6612 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6602 Remote Similarity NPD9093 Approved
0.6596 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6589 Remote Similarity NPD4339 Clinical (unspecified phase)
0.6589 Remote Similarity NPD1164 Approved
0.6575 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6575 Remote Similarity NPD2801 Approved
0.6574 Remote Similarity NPD9295 Approved
0.6573 Remote Similarity NPD1653 Approved
0.656 Remote Similarity NPD1651 Approved
0.6557 Remote Similarity NPD9281 Approved
0.6552 Remote Similarity NPD9244 Approved
0.6549 Remote Similarity NPD9495 Approved
0.6544 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6535 Remote Similarity NPD1535 Discovery
0.6535 Remote Similarity NPD3705 Approved
0.6532 Remote Similarity NPD318 Approved
0.6532 Remote Similarity NPD856 Approved
0.6532 Remote Similarity NPD16 Approved
0.6532 Remote Similarity NPD317 Approved
0.6529 Remote Similarity NPD821 Approved
0.6529 Remote Similarity NPD5535 Approved
0.6528 Remote Similarity NPD824 Approved
0.6525 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6525 Remote Similarity NPD4357 Discontinued
0.6514 Remote Similarity NPD9258 Approved
0.6514 Remote Similarity NPD9256 Approved
0.6512 Remote Similarity NPD1283 Approved
0.6508 Remote Similarity NPD1778 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data